Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)💬 Info on mouse-over

121 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
2件: PML, RARA 💬 D00094 💬 Tretinoin 5件:  2 , 63, 75, 94, 231 💬
2 Adherens junction 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
3 Adherens junction 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
4 Adherens junction 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
5 Adipocytokine signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
6 Adipocytokine signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
7 Adipocytokine signaling pathway 💬
3件: RXRA, RXRB, RXRG 💬 D03106 💬 Bexarotene 2件: 13, 75 💬
8 Adrenergic signaling in cardiomyocytes 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
9 AGE-RAGE signaling pathway in diabetic complications 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
10 Alcoholism 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
11 Alcoholism 💬
11件: HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9 💬 D06320 💬 Vorinostat 3件: 19, 75, 96 💬
12 Aldosterone synthesis and secretion 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
13 Aldosterone synthesis and secretion 💬
1件: CYP11B2 💬 D11061 💬 Osilodrostat 1件: 75 💬
14 Aldosterone synthesis and secretion 💬
1件: MC2R 💬 D00146 💬 Corticotropin 13件:  2 , 13, 14, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 💬
15 Aldosterone-regulated sodium reabsorption 💬
1件: NR3C2 💬 D01115 💬 Eplerenone 4件: 75, 113, 210, 215 💬
16 Amphetamine addiction 💬
2件: HDAC1, HDAC2 💬 D06320 💬 Vorinostat 3件: 19, 75, 96 💬
17 AMPK signaling pathway 💬
1件: PPARG 💬 D00596 💬 Rosiglitazone 5件: 46, 75, 97, 222, 265 💬
18 AMPK signaling pathway 💬
1件: PPARG 💬 D08491 💬 Rosiglitazone 5件: 46, 75, 97, 222, 265 💬
19 AMPK signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
20 AMPK signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
21 Amyotrophic lateral sclerosis 💬
1件: HDAC6 💬 D06320 💬 Vorinostat 3件: 19, 75, 96 💬
22 Apelin signaling pathway 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
23 Apelin signaling pathway 💬
2件: HDAC4, HDAC5 💬 D06320 💬 Vorinostat 3件: 19, 75, 96 💬
24 Apelin signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
25 Apelin signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
26 Autophagy - animal 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
27 Autophagy - animal 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
28 Bile secretion 💬
1件: RXRA 💬 D03106 💬 Bexarotene 2件: 13, 75 💬
29 Bladder cancer 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
30 Bladder cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
31 Bladder cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
32 Breast cancer 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
33 Breast cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
34 Breast cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
35 Breast cancer 💬
1件: PGR 💬 D00585 💬 Mifepristone 1件: 75 💬
36 Calcium signaling pathway 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
37 Calcium signaling pathway 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
38 Calcium signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
39 Calcium signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
40 cAMP signaling pathway 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
41 cAMP signaling pathway 💬
1件: GLP1R 💬 D06404 💬 Liraglutide 3件:  6 , 75, 193 💬
42 cAMP signaling pathway 💬
1件: MC2R 💬 D00146 💬 Corticotropin 13件:  2 , 13, 14, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 💬
43 cAMP signaling pathway 💬
3件: SSTR1, SSTR2, SSTR5 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
44 cAMP signaling pathway 💬
1件: SSTR2 💬 D00442 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
45 cAMP signaling pathway 💬
1件: SSTR2 💬 D06495 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
46 Cell cycle 💬
2件: HDAC1, HDAC2 💬 D06320 💬 Vorinostat 3件: 19, 75, 96 💬
47 Central carbon metabolism in cancer 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
48 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
49 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
50 cGMP-PKG signaling pathway 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
51 cGMP-PKG signaling pathway 💬
1件: PDE5A 💬 D02008 💬 Tadalafil 7件:  6 , 51, 75, 84, 86, 113, 210 💬
52 Choline metabolism in cancer 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
53 Choline metabolism in cancer 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
54 Choline metabolism in cancer 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
55 Chronic myeloid leukemia 💬
2件: HDAC1, HDAC2 💬 D06320 💬 Vorinostat 3件: 19, 75, 96 💬
56 Circadian rhythm 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
57 Circadian rhythm 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
58 Cocaine addiction 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
59 Colorectal cancer 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
60 Colorectal cancer 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
61 Colorectal cancer 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
62 Complement and coagulation cascades 💬
1件: F10 💬 D07086 💬 Rivaroxaban 5件: 46, 49, 75, 91, 210 💬
63 Complement and coagulation cascades 💬
1件: F8 💬 D00291 💬 Desmopressin 6件:  6 , 64, 72, 75, 225, 288 💬
64 Complement and coagulation cascades 💬
1件: F8 💬 D02235 💬 Desmopressin 6件:  6 , 64, 72, 75, 225, 288 💬
65 Coronavirus disease - COVID-19 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
66 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
67 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
68 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
69 Cortisol synthesis and secretion 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
70 Cortisol synthesis and secretion 💬
1件: CYP11B1 💬 D00410 💬 Metyrapone 2件: 75, 193 💬
71 Cortisol synthesis and secretion 💬
1件: CYP11B1 💬 D05019 💬 Metyrapone 2件: 75, 193 💬
72 Cortisol synthesis and secretion 💬
1件: CYP17A1 💬 D00351 💬 Ketoconazole 3件:  8 , 13, 75 💬
73 Cortisol synthesis and secretion 💬
1件: MC2R 💬 D00146 💬 Corticotropin 13件:  2 , 13, 14, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 💬
74 Cushing syndrome 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
75 Cushing syndrome 💬
2件: CRHR1, CRHR2 💬 D03905 💬 Corticorelin 1件: 75 💬
76 Cushing syndrome 💬
2件: CRHR1, CRHR2 💬 D03592 💬 Corticorelin ovine triflutate 1件: 75 💬
77 Cushing syndrome 💬
1件: CYP11B1 💬 D00410 💬 Metyrapone 2件: 75, 193 💬
78 Cushing syndrome 💬
1件: CYP11B1 💬 D05019 💬 Metyrapone 2件: 75, 193 💬
79 Cushing syndrome 💬
1件: CYP17A1 💬 D00351 💬 Ketoconazole 3件:  8 , 13, 75 💬
80 Cushing syndrome 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
81 Cushing syndrome 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
82 Cushing syndrome 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
83 Cushing syndrome 💬
1件: MC2R 💬 D00146 💬 Corticotropin 13件:  2 , 13, 14, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 💬
84 Cytokine-cytokine receptor interaction 💬
1件: GHR 💬 D02691 💬 Somatotropin 20件:  2 ,  3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬
85 Cytokine-cytokine receptor interaction 💬
1件: PRL 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
86 Diabetic cardiomyopathy 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
87 Dopaminergic synapse 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
88 EGFR tyrosine kinase inhibitor resistance 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
89 EGFR tyrosine kinase inhibitor resistance 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
90 EGFR tyrosine kinase inhibitor resistance 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
91 Endocrine resistance 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
92 Endocrine resistance 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
93 Endocrine resistance 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
94 Endocytosis 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
95 Endocytosis 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
96 Endocytosis 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
97 Endocytosis 💬
1件: PML 💬 D00094 💬 Tretinoin 5件:  2 , 63, 75, 94, 231 💬
98 Endometrial cancer 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
99 Endometrial cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
100 Endometrial cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
101 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
102 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
103 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
104 Epstein-Barr virus infection 💬
2件: HDAC1, HDAC2 💬 D06320 💬 Vorinostat 3件: 19, 75, 96 💬
105 ErbB signaling pathway 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
106 ErbB signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
107 ErbB signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
108 Estrogen signaling pathway 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
109 Estrogen signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
110 Estrogen signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
111 Estrogen signaling pathway 💬
1件: PGR 💬 D00585 💬 Mifepristone 1件: 75 💬
112 Estrogen signaling pathway 💬
1件: RARA 💬 D00094 💬 Tretinoin 5件:  2 , 63, 75, 94, 231 💬
113 Fluid shear stress and atherosclerosis 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
114 Fluid shear stress and atherosclerosis 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
115 Focal adhesion 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
116 Focal adhesion 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
117 Focal adhesion 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
118 FoxO signaling pathway 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
119 FoxO signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
120 FoxO signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
121 FoxO signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
122 FoxO signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
123 GABAergic synapse 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
124 Gap junction 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
125 Gap junction 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
126 Gap junction 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
127 Gap junction 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
128 Gastric acid secretion 💬
1件: SSTR2 💬 D00442 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
129 Gastric acid secretion 💬
1件: SSTR2 💬 D06495 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
130 Gastric acid secretion 💬
1件: SSTR2 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
131 Gastric cancer 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
132 Gastric cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
133 Gastric cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
134 Gastric cancer 💬
1件: RARB 💬 D00094 💬 Tretinoin 5件:  2 , 63, 75, 94, 231 💬
135 Gastric cancer 💬
3件: RXRA, RXRB, RXRG 💬 D03106 💬 Bexarotene 2件: 13, 75 💬
136 Glioma 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
137 Glioma 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
138 Glioma 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
139 Glucagon signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
140 Glucagon signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
141 GnRH signaling pathway 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
142 GnRH signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
143 GnRH signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
144 Growth hormone synthesis, secretion and action 💬
1件: GHR 💬 D02691 💬 Somatotropin 20件:  2 ,  3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬
145 Growth hormone synthesis, secretion and action 💬
4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
146 Growth hormone synthesis, secretion and action 💬
1件: SSTR2 💬 D00442 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
147 Growth hormone synthesis, secretion and action 💬
1件: SSTR2 💬 D06495 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
148 Hepatitis C 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
149 Hepatitis C 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
150 Hepatitis C 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
151 Hepatitis C 💬
1件: RXRA 💬 D03106 💬 Bexarotene 2件: 13, 75 💬
152 Hepatocellular carcinoma 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
153 Hepatocellular carcinoma 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
154 Hepatocellular carcinoma 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
155 Herpes simplex virus 1 infection 💬
1件: PML 💬 D00094 💬 Tretinoin 5件:  2 , 63, 75, 94, 231 💬
156 HIF-1 signaling pathway 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
157 HIF-1 signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
158 HIF-1 signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
159 Human cytomegalovirus infection 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
160 Human cytomegalovirus infection 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
161 Human cytomegalovirus infection 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
162 Human papillomavirus infection 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
163 Human papillomavirus infection 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
164 Human papillomavirus infection 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
165 Human papillomavirus infection 💬
2件: HDAC1, HDAC2 💬 D06320 💬 Vorinostat 3件: 19, 75, 96 💬
166 Huntington disease 💬
2件: HDAC1, HDAC2 💬 D06320 💬 Vorinostat 3件: 19, 75, 96 💬
167 Huntington disease 💬
1件: PPARG 💬 D00596 💬 Rosiglitazone 5件: 46, 75, 97, 222, 265 💬
168 Huntington disease 💬
1件: PPARG 💬 D08491 💬 Rosiglitazone 5件: 46, 75, 97, 222, 265 💬
169 Hypertrophic cardiomyopathy 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
170 Hypertrophic cardiomyopathy 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
171 Influenza A 💬
1件: PML 💬 D00094 💬 Tretinoin 5件:  2 , 63, 75, 94, 231 💬
172 Insulin resistance 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
173 Insulin resistance 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
174 Insulin secretion 💬
1件: GLP1R 💬 D06404 💬 Liraglutide 3件:  6 , 75, 193 💬
175 Insulin signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
176 Insulin signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
177 JAK-STAT signaling pathway 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
178 JAK-STAT signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
179 JAK-STAT signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
180 JAK-STAT signaling pathway 💬
1件: GHR 💬 D02691 💬 Somatotropin 20件:  2 ,  3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬
181 JAK-STAT signaling pathway 💬
1件: PRL 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
182 Long-term depression 💬
1件: CRHR1 💬 D03905 💬 Corticorelin 1件: 75 💬
183 Long-term depression 💬
1件: CRHR1 💬 D03592 💬 Corticorelin ovine triflutate 1件: 75 💬
184 Longevity regulating pathway 💬
1件: PPARG 💬 D00596 💬 Rosiglitazone 5件: 46, 75, 97, 222, 265 💬
185 Longevity regulating pathway 💬
1件: PPARG 💬 D08491 💬 Rosiglitazone 5件: 46, 75, 97, 222, 265 💬
186 Longevity regulating pathway 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
187 Longevity regulating pathway 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
188 Longevity regulating pathway - multiple species 💬
2件: HDAC1, HDAC2 💬 D06320 💬 Vorinostat 3件: 19, 75, 96 💬
189 Longevity regulating pathway - multiple species 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
190 Longevity regulating pathway - multiple species 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
191 MAPK signaling pathway 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
192 MAPK signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
193 MAPK signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
194 Melanoma 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
195 Melanoma 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
196 Melanoma 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
197 Metabolic pathways 💬
1件: CYP11B1 💬 D00410 💬 Metyrapone 2件: 75, 193 💬
198 Metabolic pathways 💬
1件: CYP11B1 💬 D05019 💬 Metyrapone 2件: 75, 193 💬
199 Metabolic pathways 💬
1件: CYP11B2 💬 D11061 💬 Osilodrostat 1件: 75 💬
200 Metabolic pathways 💬
1件: CYP17A1 💬 D00351 💬 Ketoconazole 3件:  8 , 13, 75 💬
201 Metabolic pathways 💬
1件: PDE5A 💬 D02008 💬 Tadalafil 7件:  6 , 51, 75, 84, 86, 113, 210 💬
202 MicroRNAs in cancer 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
203 MicroRNAs in cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
204 MicroRNAs in cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
205 MicroRNAs in cancer 💬
4件: HDAC1, HDAC2, HDAC4, HDAC5 💬 D06320 💬 Vorinostat 3件: 19, 75, 96 💬
206 Morphine addiction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
207 mTOR signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
208 mTOR signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
209 Neuroactive ligand-receptor interaction 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
210 Neuroactive ligand-receptor interaction 💬
1件: AVPR2 💬 D00291 💬 Desmopressin 6件:  6 , 64, 72, 75, 225, 288 💬
211 Neuroactive ligand-receptor interaction 💬
1件: AVPR2 💬 D02235 💬 Desmopressin 6件:  6 , 64, 72, 75, 225, 288 💬
212 Neuroactive ligand-receptor interaction 💬
2件: CRHR1, CRHR2 💬 D03905 💬 Corticorelin 1件: 75 💬
213 Neuroactive ligand-receptor interaction 💬
2件: CRHR1, CRHR2 💬 D03592 💬 Corticorelin ovine triflutate 1件: 75 💬
214 Neuroactive ligand-receptor interaction 💬
2件: DRD2, PRL 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
215 Neuroactive ligand-receptor interaction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
216 Neuroactive ligand-receptor interaction 💬
1件: GHR 💬 D02691 💬 Somatotropin 20件:  2 ,  3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬
217 Neuroactive ligand-receptor interaction 💬
1件: GLP1R 💬 D06404 💬 Liraglutide 3件:  6 , 75, 193 💬
218 Neuroactive ligand-receptor interaction 💬
1件: MC2R 💬 D00146 💬 Corticotropin 13件:  2 , 13, 14, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 💬
219 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00292 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
220 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00975 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
221 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01510 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
222 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01615 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
223 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01632 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
224 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01948 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
225 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02174 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
226 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02591 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
227 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02592 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
228 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00088 💬 Hydrocortisone 9件:  6 , 46, 53, 75, 78, 81, 83, 97, 299 💬
229 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00585 💬 Mifepristone 1件: 75 💬
230 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00472 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
231 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00980 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
232 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00981 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
233 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00982 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
234 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01239 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
235 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01998 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
236 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02156 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
237 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D03301 💬 Prednisolone 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
238 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D11336 💬 Relacorilant 1件: 75 💬
239 Neuroactive ligand-receptor interaction 💬
4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
240 Neuroactive ligand-receptor interaction 💬
1件: SSTR2 💬 D00442 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
241 Neuroactive ligand-receptor interaction 💬
1件: SSTR2 💬 D06495 💬 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227 💬
242 Neutrophil extracellular trap formation 💬
11件: HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9 💬 D06320 💬 Vorinostat 3件: 19, 75, 96 💬
243 Nicotine addiction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00549 💬 Propofol 9件:  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
244 Non-alcoholic fatty liver disease 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
245 Non-alcoholic fatty liver disease 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
246 Non-alcoholic fatty liver disease 💬
1件: RXRA 💬 D03106 💬 Bexarotene 2件: 13, 75 💬
247 Non-small cell lung cancer 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
248 Non-small cell lung cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
249 Non-small cell lung cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
250 Non-small cell lung cancer 💬
1件: RARB 💬 D00094 💬 Tretinoin 5件:  2 , 63, 75, 94, 231 💬
251 Non-small cell lung cancer 💬
3件: RXRA, RXRB, RXRG 💬 D03106 💬 Bexarotene 2件: 13, 75 💬
252 Notch signaling pathway 💬
2件: HDAC1, HDAC2 💬 D06320 💬 Vorinostat 3件: 19, 75, 96 💬
253 Oocyte meiosis 💬
1件: PGR 💬 D00585 💬 Mifepristone 1件: 75 💬
254 Osteoclast differentiation 💬
1件: PPARG 💬 D00596 💬 Rosiglitazone 5件: 46, 75, 97, 222, 265 💬
255 Osteoclast differentiation 💬
1件: PPARG 💬 D08491 💬 Rosiglitazone 5件: 46, 75, 97, 222, 265 💬
256 Ovarian steroidogenesis 💬
1件: CYP17A1 💬 D00351 💬 Ketoconazole 3件:  8 , 13, 75 💬
257 Oxytocin signaling pathway 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
258 Oxytocin signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
259 Oxytocin signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
260 Oxytocin signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
261 Oxytocin signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
262 Pancreatic cancer 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
263 Pancreatic cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
264 Pancreatic cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
265 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
266 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
267 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
268 Parathyroid hormone synthesis, secretion and action 💬
3件: RXRA, RXRB, RXRG 💬 D03106 💬 Bexarotene 2件: 13, 75 💬
269 Parkinson disease 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
270 Pathways in cancer 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
271 Pathways in cancer 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
272 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
273 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
274 Pathways in cancer 💬
2件: HDAC1, HDAC2 💬 D06320 💬 Vorinostat 3件: 19, 75, 96 💬
275 Pathways in cancer 💬
3件: PML, RARA, RARB 💬 D00094 💬 Tretinoin 5件:  2 , 63, 75, 94, 231 💬
276 Pathways in cancer 💬
1件: PPARG 💬 D00596 💬 Rosiglitazone 5件: 46, 75, 97, 222, 265 💬
277 Pathways in cancer 💬
1件: PPARG 💬 D08491 💬 Rosiglitazone 5件: 46, 75, 97, 222, 265 💬
278 Pathways in cancer 💬
3件: RXRA, RXRB, RXRG 💬 D03106 💬 Bexarotene 2件: 13, 75 💬
279 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
280 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
281 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
282 Phospholipase D signaling pathway 💬
1件: AGTR1 💬 D00400 💬 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224 💬
283 Phospholipase D signaling pathway 💬
1件: AVPR2 💬 D00291 💬 Desmopressin 6件:  6 , 64, 72, 75, 225, 288 💬
284 Phospholipase D signaling pathway 💬
1件: AVPR2 💬 D02235 💬 Desmopressin 6件:  6 , 64, 72, 75, 225, 288 💬
285 Phospholipase D signaling pathway 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
286 Phospholipase D signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
287 Phospholipase D signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
288 PI3K-Akt signaling pathway 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
289 PI3K-Akt signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
290 PI3K-Akt signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
291 PI3K-Akt signaling pathway 💬
1件: GHR 💬 D02691 💬 Somatotropin 20件:  2 ,  3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬
292 PI3K-Akt signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D00944 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
293 PI3K-Akt signaling pathway 💬
2件: PRKAA1, PRKAA2 💬 D04966 💬 Metformin 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
294 PI3K-Akt signaling pathway 💬
1件: PRL 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
295 PI3K-Akt signaling pathway 💬
1件: RXRA 💬 D03106 💬 Bexarotene 2件: 13, 75 💬
296 Platinum drug resistance 💬
1件: ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
297 Platinum drug resistance 💬
1件: ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
298 PPAR signaling pathway 💬
1件: PPARG 💬 D00596 💬 Rosiglitazone 5件: 46, 75, 97, 222, 265 💬
299 PPAR signaling pathway 💬
1件: PPARG 💬 D08491 💬 Rosiglitazone 5件: 46, 75, 97, 222, 265 💬
300 PPAR signaling pathway 💬
3件: RXRA, RXRB, RXRG 💬 D03106 💬 Bexarotene 2件: 13, 75 💬
301 Progesterone-mediated oocyte maturation 💬
1件: PGR 💬 D00585 💬 Mifepristone 1件: 75 💬
302 Prolactin signaling pathway 💬
1件: CYP17A1 💬 D00351 💬 Ketoconazole 3件:  8 , 13, 75 💬
303 Prolactin signaling pathway 💬
1件: PRL 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
304 Prostate cancer 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
305 Prostate cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
306 Prostate cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
307 Protein digestion and absorption 💬
1件: DPP4 💬 D08516 💬 Sitagliptin 4件:  6 , 75, 233, 299 💬
308 Proteoglycans in cancer 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
309 Proteoglycans in cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
310 Proteoglycans in cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
311 Purine metabolism 💬
1件: PDE5A 💬 D02008 💬 Tadalafil 7件:  6 , 51, 75, 84, 86, 113, 210 💬
312 Rap1 signaling pathway 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
313 Rap1 signaling pathway 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
314 Rap1 signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
315 Rap1 signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
316 Ras signaling pathway 💬
1件: EGFR 💬 D01977 💬 Gefitinib 1件: 75 💬
317 Ras signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
318 Ras signaling pathway 💬